Cryofocus Medtech (Shanghai) Co., Ltd. (6922.HK)
Market: HKEX |
Currency: HKD
Address: Building 15
Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, develops, produces, and sells minimally-invasive interventional cryotherapy products in the People's Republic of China. The company develops products in the areas of vascular interventional therapy for the treatment of atrial fibrillation, hypertension, and other cardiovascular diseases; and natural orifice transluminal endoscopic surgery for the treatment of urinary, respiratory, and digestive diseases. Its products include Bladder Cryoablation System, a cryotherapy device for the treatment of non-muscle-invasive bladder cancer; pulmonary nodule localization needle for CT-guided localization of lung nodules; endoscopic clip for anastomosis for the closure of soft tissue in digestive tract; and laparoscopic single port multi-channel access platform for laparoscopic surgery. The company's products also comprise wound retractors for small incision surgery and minimally invasive surgery; ureteral dilation balloon catheter for ureteral stricture; laparoscopic biopsy bag for biopsy; and laparoscopic surgical instrument for laparoscopy application. The company was incorporated in 2013 and is based in Shanghai, the People's Republic of China.
Show more
📈 Cryofocus Medtech (Shanghai) Co., Ltd. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
25-50%
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Cryofocus Medtech (Shanghai) Co., Ltd.
No earnings history available for this symbol.
📰 Related News & Research
No related articles found for "cryofocus medtech".